XML 88 R79.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Liabilities - 2027 Term Loan - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
May 08, 2024
Apr. 01, 2024
Feb. 05, 2024
Dec. 31, 2024
Dec. 31, 2024
Jan. 05, 2022
Debt Instrument [Line Items]            
Interest rate       12.60%    
Debt partial prepayment to be Made     $ 175,000      
Minimum net sales convenant level agreed to be maintained over past year     $ 125,000      
Loss on debt extinguishment         $ 12,630  
2027 Term Loans            
Debt Instrument [Line Items]            
Principal amount   $ 250,000   $ 250,000 $ 250,000  
Interest rate         0.26161%  
Spread on variable rate         1.00%  
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]         us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember  
Partial prepayment of principal   175,000        
Outstanding amount paid off   $ 181,900     $ 260,387  
2027 Term Loans | BioPharma Credit Investments V GP LLC            
Debt Instrument [Line Items]            
Principal amount           $ 300,000
Funded amount           $ 250,000
Stated interest rate           8.25%
Prepayment premium percentage 3.00%          
Loss on debt extinguishment         $ 12,600  
Outstanding amount payoff $ 79,600